Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Endologix Announces Presentation of Favorable Initial PEVAR Trial Results

February 15, 2011 By Bio-Medicine.Org

IRVINE, Calif., Feb. 15, 2011 /PRNewswire/ — Endologix, Inc.
(Nasdaq:
ELGX
), developer of minimally invasive treatments for aortic
disorders, announced today the presentation of the initial clinical
results from the PEVAR Trial at the 2011 iCON (International
Congress of Endovascular Specialists) annual meeting in Scottsdale,
Arizona. Among 33 patients enrolled in the Roll-In phase of the
trial, technical success rates of 97% (access) and 100%
(endovascular repair) have been achieved, with no major adverse
events observed. Patients were discharged from the hospital at an
average of 1.4 days following the procedure.

Participating investigator and presenter Zvonimir Krajcer, MD
(Director, Peripheral Vascular Disease Service, St. Luke’s
Episcopal Hospital at the Texas Heart Institute, Houston, TX)
commented, “In our multidisciplinary practice, a totally
percutaneous approach to endovascular repair with the IntuiTrak
System and Abbott’s Prostar XL closure device has demonstrated
substantial patient benefits as we recently reported in the
Journal of Cardiovascular Surgery.   These initial
outcomes in the PEVAR Trial roll-in phase are consistent with the
published single center data, and have served to support initiation
of the randomized phase of the trial. We are very pleased with the
initial results, and look forward to completion of the randomized
trial very soon.”

The PEVAR Trial is the first multicenter, prospective,
randomized trial of totally percutaneous endovascular repair of
abdominal aortic aneurysm and is being conducted at 20 centers in
the United States under an Investigational Device Exemption
approved by the U.S. Food and Drug Administration.

John McDermott, President and Chief Executive Officer said, “We
applaud the PEVAR Trial investigators for their diligence and
dedication to the trial, and commitment to improving patient
outcomes. We

‘/>”/>

SOURCE

Related Articles Read More >

A pulse oximeter device being used on a patient's finger
Senators seek post-market FDA study of pulse oximeters and skin color
Connected device design for the real world: Managing the development process
A portrait of ResMed President and COO Rob Douglas
ResMed finds a solution to semiconductor shortage, as well as some humor in it
Johnson & Johnson Office of Digital Innovation Leader Peter Schulam
Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech